Literature DB >> 11570544

Dental and oral manifestations of sclerosteosis.

L X Stephen1, H Hamersma, J Gardner, P Beighton.   

Abstract

AIMS AND
OBJECTIVES: Documentation of the oral and dental manifestations of Sclerosteosis. SETTING AND PARTICIPANTS: Sclerosteosis is a member of the family of genetic craniotubular hyperostoses. This severe progressive sclerosing bone dysplasia has important orofacial manifestations and a wide geographical distribution. Comprehensive oral and dental evaluation of eight affected adults in the Afrikaner community of South Africa was undertaken.
RESULTS: Gross asymmetrical hypertrophy of the mandible was present in all eight patients, bilateral or unilateral facial paralysis with weakness of facial muscles due to facial nerve entrapment was present in six. Drooling of saliva and difficulties with mastication were frequent problems in these persons. The teeth were structurally and mechanically normal although there was partial anodontia in two patients and delayed eruption in another. Maxillary (palatal) and mandibular tori were present in every affected person. Due to the hyperostosis of the maxilla and mandible, tooth extraction was often a very difficult matter. There were no instances of post-extraction osteomyelitis of the mandible.
CONCLUSIONS: Accurate differentiation of sclerosteosis from the other sclerosing bone dysplasias is crucial for effective dental prognostication and management.

Entities:  

Mesh:

Year:  2001        PMID: 11570544     DOI: 10.1002/j.1875-595x.2001.tb00840.x

Source DB:  PubMed          Journal:  Int Dent J        ISSN: 0020-6539            Impact factor:   2.512


  10 in total

1.  PERP regulates enamel formation via effects on cell-cell adhesion and gene expression.

Authors:  Andrew H Jheon; Pasha Mostowfi; Malcolm L Snead; Rebecca A Ihrie; Eli Sone; Tiziano Pramparo; Laura D Attardi; Ophir D Klein
Journal:  J Cell Sci       Date:  2011-02-01       Impact factor: 5.285

2.  High-bone-mass-producing mutations in the Wnt signaling pathway result in distinct skeletal phenotypes.

Authors:  Paul J Niziolek; Takeisha L Farmer; Yajun Cui; Charles H Turner; Matthew L Warman; Alexander G Robling
Journal:  Bone       Date:  2011-08-09       Impact factor: 4.398

Review 3.  Sclerostin is a promising therapeutic target for oral inflammation and regenerative dentistry.

Authors:  Chufang Liao; Shanshan Liang; Yining Wang; Ting Zhong; Xiangning Liu
Journal:  J Transl Med       Date:  2022-05-13       Impact factor: 8.440

Review 4.  The role of sclerostin and dickkopf-1 in oral tissues - A review from the perspective of the dental disciplines.

Authors:  Mohammad Samiei; Klara Janjić; Barbara Cvikl; Andreas Moritz; Hermann Agis
Journal:  F1000Res       Date:  2019-01-30

Review 5.  A Roadmap to Gene Discoveries and Novel Therapies in Monogenic Low and High Bone Mass Disorders.

Authors:  Melissa M Formosa; Dylan J M Bergen; Celia L Gregson; Antonio Maurizi; Anders Kämpe; Natalia Garcia-Giralt; Wei Zhou; Daniel Grinberg; Diana Ovejero Crespo; M Carola Zillikens; Graham R Williams; J H Duncan Bassett; Maria Luisa Brandi; Luca Sangiorgi; Susanna Balcells; Wolfgang Högler; Wim Van Hul; Outi Mäkitie
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-13       Impact factor: 5.555

6.  Molecular Basis for Craniofacial Phenotypes Caused by Sclerostin Deletion.

Authors:  J Chen; X Yuan; I Pilawski; X Liu; J Delgado-Calle; T Bellido; H Turkkahraman; J A Helms
Journal:  J Dent Res       Date:  2020-10-20       Impact factor: 6.116

Review 7.  Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management.

Authors:  Celia L Gregson; Sarah A Hardcastle; Cyrus Cooper; Jonathan H Tobias
Journal:  Rheumatology (Oxford)       Date:  2013-02-27       Impact factor: 7.580

8.  Dental and periodontal phenotype in sclerostin knockout mice.

Authors:  Ulrike Kuchler; Uwe Y Schwarze; Toni Dobsak; Patrick Heimel; Dieter D Bosshardt; Michaela Kneissel; Reinhard Gruber
Journal:  Int J Oral Sci       Date:  2014-04-04       Impact factor: 6.344

Review 9.  The Genetic Architecture of High Bone Mass.

Authors:  Celia L Gregson; Emma L Duncan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-29       Impact factor: 5.555

10.  Bioactivating a bone substitute accelerates graft incorporation in a murine model of vertical ridge augmentation.

Authors:  Jinlong Chen; Xue Yuan; Zhijun Li; Daniel J Bahat; Jill A Helms
Journal:  Dent Mater       Date:  2020-07-07       Impact factor: 5.304

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.